Congressional spending plan: What’s in it for healthcare, and what isn’t
Chief Healthcare Executive December 21, 2024
Hims & Hers, and the Brewing GLP-1 Compounding Controversy
Hospitalogy August 7, 2024
GLP-1s are on track to be one of the most profitable drug classes of all time – and everyone wants in on the action.
With the growing conversation around obesity, there’s also a controversy bubbling under the surface ready to overflow.
No, I’m not talking about my terrible pasta making skills (how do you...
Today's Sponsors
Today's Sponsor